Aim: Serum osteocalcin was shown in a previous study on first trimester pregnant women to correlate with bone density and to distinguish between fast and slow bone losers. The objective of the present study is to examine whether serum osteocalcin is related to vitamin D receptor (VDR) BsmI polymorphism in pregnant women. Study design: We determined osteocalcin serum levels and VDR BsmI genotype in 97 healthy first trimester pregnant women consecutively recruited during six months. Results: BB (21%), Bb (38%) and bb (41%) genotypes showed similar osteocalcin serum levels. However, in primigravidas (ns38) the BB genotype was significantly associated with higher mean osteocalcin level (9.67 ng/mL) than the Bb (8.07 ng/mL) and the bb genotype (8.14 ng/mL), respectively (P-0.05). The VDR genotype was the only independent parameter to correlate with serum osteocalcin (P-0.05). Conclusion: Only primigravidas show in the first trimester a relation between the bone formation parameter serum osteocalcin and the VDR genotype BB which indicates a higher risk of fractures. For further clinical applications serum osteocalcin and VDR genotype should be tested on a cohort of primigravidas including measurements of bone density.
Introduction
Osteoporosis is a multifactorial disease that involves a reduction in bone mineral density (BMD). Since osteoporosis is a late-onset disease, the development of early diagnostic modalities and preventive measures are urgently required. Environmental and genetic factors are interacting in establishing the individual osteoporotic risk. Among multiple candidate genes in relation to BMD, such as estrogen receptor and collagen I gene polymorphisms, in addition to the TGFb1-regulating genes w4x, the vitamin D receptor (VDR) gene at the 3' end allele was the first described w15x. BsmI polymorphism is one of the four VDR gene polymorphisms known to date, which are differently related to BMD. Age, gender, race and diet play key roles. Therefore, crucial relations of VDR polymorphism and BMD exist from studies with different populations.
Post-menopausal women are the major at-risk subgroup for osteoporosis w8x. Moreover, pregnancy has different impact on bone mineral metabolism and density w6, 9x. In a meta-analysis, mean loss of BMD was considered as up to 5% w9x. However, it could be shown that women with many children had similar or higher BMD than their nulliparous controls. Parity obviously does not increase the risk of BMD loss or other factors may be determinants such as bone metabolism in pregnancy. We recently demonstrated that trabecular bone density in pregnancy varied between slow and fast bone losers during the first trimester w19x. Thereby, the only independent biochemical parameter significantly associated with the rate of bone loss was serum osteocalcin which could distinguish slow from fast losers. BsmI polymorphism occurs in 18% in Caucasian population with the BB genotype w4, 8x. The first study with sufficient statistical power included white nurses in a health cohort and demonstrated a two-fold increase in the risk of hip fractures among BB genotypes in association with older age and lower calcium intake w5x.
Osteocalcin gene expression is regulated by the VDR gene w14x. It was the goal of the present study to prospectively test if higher osteocalcin levels indicating fast bone losers are also associated with the BB genotype. Bone chemistry in our previous study was not consistent between first and third trimester demonstrating pregnancy associated adaptations. From these results we suggested that bone metabolism may change within pregnancy and we hypothesized for our present study that gravidity i.e., the first pregnancy, could also play an 
Material and methods

Subjects
Following approval of the local ethical committee and with their informed consent, we consecutively recruited healthy first trimester pregnant primigravidas and multigravidas during routine control in the Obstetric Clinic of Zurich University Hospital, Switzerland over a 6-month period. Inclusion criteria to this prospective study were uncomplicated singleton pregnancies between 10.0 and 16.0 weeks of gestation by ultrasound. Exclusion criteria were multiple gestation, age -18 and )40.0 years, BMI )30.0 at inclusion, preexisting maternal diseases such as diabetes and hypothyroidism, and drug abuse (incl. tobacco). Patient data were obtained from the patient notes. Venous blood (3 mL) was collected between 8:00 and 10:00 am into EDTA containing tubes which were stored at -808C until analysis of VDR; 10 mL were collected into native tubes kept immediately at 48C and centrifuged 10 min after venepuncture at 48C, the serum was immediately transferred into 800 mL aliquots for storage at -208C until analysis of osteocalcin.
Laboratory methods
Vitamin D receptor (VDR) genotype Peripheral blood collected in EDTA vacutainers was frozen (whole blood) and stored at -808C until extraction. Genomic DNA was extracted from whole blood by MagNA pure compact instrument using the MPC nucleic acid isolation kit I according to the manufacturer's instructions (Roche Applied Science, Germany) and quantified by UV absorption at 260 nm. Genotyping of the single nucleotide polymorphism BsmI (A)G in intron 8) was performed by PCR amplification of a region of the VDR gene spanning the BsmIsite, followed by restriction endonuclease digestion. After digestion DNA fragments were separated on ethidium-bromide stained 2% agarose gels and VDR genotype was determined by UV illumination, identifying the wild type allele or the mutated allele, respectively. Homozygous presence of the wild type site (bb) resulted in two fragments of 195 base pairs (bp) and 164 bp, while homozygous absence of the restriction site (mutated site BB) resulted in a single fragment of 359 bp. A heterozygous genotype (Bb) was identified by DNA fragments of 359 bp, 195 bp and 164 bp.
Osteocalcin Osteocalcin in serum was measured by enzyme immunoassay (EIA; osteocalcin intact human) from Metraீ (www.teco-medical.ch) (intra-assay variation -6%, inter-assay variation -10%; detection limit 0.45 ng/mL). Samples were assayed in duplicates (the mean value was used) according to the manufacturer's protocol. In a precedent setting six different samples were analyzed by both, the EIA and the previously used IRMA method w19x which is not anymore commercially available and the values were compared by using the Bland-Altmann-Plot w2x. It could be shown that IRMA values were 2.14 lower than EIA values (mean ratio 2.14 with limits of agreement between 2.00 and 2.27).
Endpoints
The primary endpoint was the relationship between VDR genotype and serum osteocalcin in the typical population of our clinic. The second endpoint was the comparison of such a relationship between primi-and multigravidas.
Statistical analysis
Statistical analysis was performed using SPSS 10 for Windows. Data are expressed as mean"SE. Differences between groups were examined using the Mann-Whitney U-test as well as the unpaired two-tailed t-tests of log values. Group interactions with other parameters were tested using analysis of variance (ANO-VA) . Correlations between variables were tested by logistic and simple regression. A P-0.05 was considered significant in all tests. The sample size of 20 (in each group) was adequate (power )80%, as0.05) for detecting a difference )20% between the median of osteocalcin serum concentration in different VDR genotypes.
Results
Subjects
After the exclusion of three falsely recruited women who did not meet the inclusion criteria (one with a BMI of 31.0 kg/m 2 and two with multiple pregnancy), the population numbered ns97 first trimester pregnant women with a mean age of 28.4 years and an actual BMI of 22.9 kg/m 2 . The majority of women were Caucasians (76.3%) ( Table 1) . Data for the outcome of pregnancy could be recorded in ns94; one woman had an abortion in the 18 th week, and two women delivered out of the country. The outcome of these 94 women was uncomplicated in 78.7%. Four women had gestational diabetes without further problems and two had mild preeclampsia (edema; proteinuria F5 g/24 h, systolic/diastolic blood pressure )140F160/)90F110 mm Hg). Three women had other complications (streptococcus B infection ns1, toxoplasmosis infection ns1, fetal malformation ns1). The mean gestational age at delivery was 39.3 weeks; six women delivered between 35.0 and 37.0 weeks.
Figure 1 (A) Mean"SE osteocalcin serum concentration (ng/mL) in VDR BsmI genotypes showing significantly higher levels in primigravidas with the BB allele (ns6) than with the Bb (ns17) or bb (ns15) alleles or than in multigravidas (BB, ns14; Bb, ns20; bb, ns25), *P-0.05 (Mann-Whitney U-test and unpaired t-test of log values, respectively). (B) Mean"SE osteocalcin serum concentration (ng/mL) in VDR BsmI genotypes showing no significantly different levels in nulliparas with the BB allele (ns9) than with the Bb (ns23) or bb (ns19) alleles or than in multiparas (BB, ns11; Bb, ns14; bb, ns21). 
Vitamin D receptor (VDR) genotype and serum osteocalcin
While bb was the most prevalent VDR BsmI genotype (41.3%), BB was the least prevalent (20.6%) in this group of women (ns97). In our Caucasian women (ns74) the distribution was 23%, 37.8% and 39.2%, in Asian women (ns12) 16.7%, 33.3% and 50%, and in African women (ns9) 11.1%, 33.3% and 55.6% for BB, Bb and bb genotypes, respectively. The two Oriental women had both the Bb genotype. The BB homozygotes were associated with higher serum osteocalcin levels compared with the Bb heterozygotes or the bb homozygotes (Table  2 ). In primigravidas (ns38) the difference was statistically significant (9.67 ng/mL in BB vs. 8.07 ng/mL in Bb and 8.14 ng/mL in bb genotypes; P-0.05) ( Figure 1A) . No significant differences were found between nulliparas and multiparas ( Figure 1B) , nor between women with and without pregnancy complications (data not shown). There were also no differences between the subgroup of Caucasians and the whole collective (Table 2) . Osteocalcin values in primigravidas ranged between 6.06 and 16.63 ng/mL suggesting a 2.14-fold higher level than in our previous study determined by the IRMA method w19x. The ROC curve showed that an osteocalcin concentration of 7.19 ng/mL in primigravidas discriminated between fast and slow losers with 53.1% sensitivity and 100% specificity (Figure 2 ). The VDR genotype was the only independent variable correlating with osteocalcin in fast and slow losers in a logistic regression model (P-0.05) including age and BMI in primigravidas (Table 3) .
Discussion
To our knowledge, no previous study exists demonstrating higher osteocalcin levels in pregnancy and its relation to the VDR genotype BB.
The new finding in our study is that only primigravidas show the association between osteocalcin serum concentrations and VDR based on a number of robust findings. Blood sampling for osteocalcin was standardized (time of blood sampling, handling and storage of serum).
The concentration which discriminates between fast and slow bone loser was 7.19 ng/mL corresponding to 3.36 ng/mL which is similar to that found in our previous study (3.67 ng/mL). We could also show that no other independent variables exist other than VDR genotype that correlates with osteocalcin levels. The distribution of VDR genotype at the gene locus BsmI in our Caucasians was similar (23%) to that in previously published studies (18-20%) w4, 8x. However, in our Asians (ns12), the BB genotype occurred more frequent (16%) than in other studies with Asians (1-2%) w4, 10, 18, 20x. There are also some limitations in our study. For example, since higher osteocalcin levels correlated with the BB genotype, we had only a small number of primigravidas with this genotype (all, ns38; BB genotype, ns6). We also did not account the consumption of calcium because in our previous study w19x we could demonstrate that bone density was independent from calcium intake.
The fact that a relationship exists between higher osteocalcin serum levels and VDR BB genotype in primigravidas supports the regulatory role of VDR gene in bone metabolism as well as different bone metabolism changes in primigravidas compared to multigravidas. Simultaneous bone biochemistry in our previous study indicated that bone turnover is subject to change during pregnancy. These pregnancy associated changes have also been demonstrated by others w6x. According to our previous study, in which we could also demonstrate that serum osteocalcin reflects bone density by differentiating fast from slow bone losers, primigravidas with the BB genotype of the present study are also associated with higher bone mass losing. In fact, osteocalcin is related to the current bone mass and provides information about future bone loss and fracture risk, as a five-year followup study in premenopausal Swedish women has recently shown w12x. In addition, it could be shown that the effect of the calcitriol-stimulated osteocalcin secretion in human osteoblasts was doubled in the bb genotype compared with the BB genotype w16x. However, the association between VDR gene BsmI polymorphism and BMD remains controversial. Gender, age (children vs. adolescents vs. premenopausal vs. postmenopausal women), race and ethnicity are the most important influencing factors which could be accounted for the great diversity between numerous studies w1, 3, 7, 11, 13, 17x.
Moreover, we failed to detect the influence of parity confirming by several studies which showed similar or higher BMD in women with many children than in nulliparous controls w9x.
In conclusion, only primigravidas show in the first trimester a relation between the bone formation parameter serum osteocalcin and the VDR genotype BB which is known to indicate a higher risk of fractures. For further clinical applications, serum osteocalcin and VDR genotype should be tested on a cohort of primigravidas including measurements of bone density in pregnancy as well as before and after menopause.
